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Type I IFN enhances follicular B cell
contribution to the T cell–independent
antibody response

1Integrated

Department of Immunology, University of Colorado, Denver, and National Jewish Health, Denver, CO 80206
of Pathology and Immunology, Washington University, St. Louis, MO 63110

The Journal of Experimental Medicine

2Department

Humoral immunity to viruses and encapsulated bacteria is comprised of T cell–independent
type 2 (TI-2) antibody responses that are characterized by rapid antibody production by
marginal zone and B1 B cells. We demonstrate that toll-like receptor (TLR) ligands
influence the TI-2 antibody response not only by enhancing the overall magnitude but also
by skewing this response to one that is dominated by IgG isotypes. Importantly, TLR ligands
facilitate this response by inducing type I interferon (IFN), which in turn elicits rapid and
significant amounts of antigen-specific IgG2c predominantly from FO (follicular) B cells.
Furthermore, we show that although the IgG2c antibody response requires B cell–
autonomous IFN- receptor signaling, it is independent of B cell–intrinsic TLR signaling.
Thus, innate signals have the capacity to enhance TI-2 antibody responses by promoting
participation of FO B cells, which then elaborate effective IgG anti-pathogen antibodies.

CORRESPONDENCE
Raul M. Torres:
torresr@njhealth.org
Abbreviations used: dsRNA,
double-stranded RNA; MZ,
marginal zone; PAMP,
pathogen-associated molecular
pattern; PRR, pattern
recognition receptor; TD,
T cell dependent; TI, T cell
independent; TLR, Tolllike receptor.

The peripheral pool of mature B cells in adults
is composed of several subpopulations, each of
which is generally thought to make a distinct
contribution to humoral immunity. As an ex
ample, natural serum IgM functions as a first
line of defense against pathogens and is pro
duced primarily by B1a B cells before exposure
(Baumgarth et al., 1999; Haas et al., 2005).
Upon bacterial or viral infection, marginal zone
(MZ) and B1 B cell subsets respond rapidly,
constituting the immediate acquired antibody
response (Martin et al., 2001). Finally, FO (fol
licular) B cells dominate the delayed highly
specific antibody response comprised by soma
tically mutated higher affinity class-switched
antibodies and memory B cells. These latter
processes occur in germinal center reactions
that occur after productive interactions between
responding B cells and antigen-specific helper
T cells (Martin and Kearney, 2002; McHeyzerWilliams, 2003).
The nature of the antigen itself can also
dictate which B cell subset is recruited into
an antibody response. Using model antigens in
rodents, B cell antigens have been classified as
either T cell independent (TI) or T cell depen
dent (TD). TI antigens promote B cell prolifer
ation, differentiation, and antibody production
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in the absence of T cells and are further clas
sified into two subgroups: type I (TI-1) or
type 2 (TI-2). TI-1 antigens are mitogens that
stimulate all B cells to produce antibody in
a polyclonal manner and irrespective of an
tigen specificity. Physiological TI-1 antigens
include Toll-like receptor (TLR) ligands, such
as LPS which is expressed by gram negative
bacteria (Coutinho et al., 1974), or certain
viral coat proteins (Berberian et al., 1993; Blutt
et al., 2004). TI-2 antigens are instead com
posed of repetitive epitopes displayed on a
backbone that simultaneously engage multiple
antigen receptors on the surface of antigenspecific B cells. TI-2 antigens elicit robust IgM
and IgG3 antibody production in a TI fashion,
although the presence of noncognate T cell
help promotes production of other IgG iso
types (Mongini et al., 1984). These TI antigens
include polysaccharides found on encapsulated
bacteria and highly organized viral capsid pro
teins such as those found on vesicular stomatitis
virus and poliovirus (Bachmann et al., 1995;
© 2010 Swanson et al. This article is distributed under the terms of an
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first
six months after the publication date (see http://www.rupress.org/terms). After
six months it is available under a Creative Commons License (Attribution–
Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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result of innate immune receptor signaling contributes to
regulating the antibody response.
It has been proposed that in addition to their antigenspecific BCR, B cells may also use innate mechanisms for
pathogen recognition. However, it is still unclear which of
the innate receptors are used by B cells or what the conse
quence of these signals is to the B cell antibody response. The
rapid TI-2 antibody response provides a temporal bridge be
tween the early innate and late adaptive immune responses.
Thus, we were interested to investigate how innate signals
would augment the TI-2 antibody response and influence
the different B cell populations during this response.
In this paper, we show that TLR agonists significantly
enhance the TI-2 antibody response through the elaboration
of type I IFN that promotes production of IgG2c by FO
B cells. This contribution elicited by FO B cells is shown to
accelerate the kinetics and enhance the magnitude and qual
ity of the TI-2 antibody response. Thus, these data not only
provide a mechanistic example of how innate immunity
influences adaptive immunity but also define how humoral
immunity counters physiological pathogens that present TI-2
antigens in the presence of ligands for innate immune receptors.
RESULTS
Poly(I:C) enhances the magnitude and kinetics of the TI-2
antibody response
Poly(I:C) is a synthetic double-stranded RNA (dsRNA) that
mimics viral nucleic acids and is recognized by several innate
PRRs, including the TLR3 receptor. MZ B cells are consid
ered to be largely responsible for the antibody response to
TI-2 antigens (Martin et al., 2001) and express significantly
higher levels of the TLR3 transcript than FO B cells (Genestier
et al., 2007). Thus, we questioned how poly(I:C) might in
fluence the TI-2 antibody response by immunizing mice
with the model TI-2 antigen NP-Ficoll in the presence or
absence of poly(I:C). These results demonstrated that poly(I:C)
markedly enhanced the antigen-specific IgG3 and IgG2c
antibody responses at both day 4 and day 7 after immuniza
tion (Fig. 1 A). In contrast, poly(I:C) did not alter the day-4
IgM response but instead promoted a significant decrease in
the NP-specific IgM response of 1.6-fold at 7 d after immu
nization (Fig. 1 A).
Overall, poly(I:C) led to a twofold increase in total
antigen-specific Ig 7 d after immunization (Fig. 1 B). The
composition of the TI-2 antigen-specific antibody response
was skewed by poly(I:C) from an IgM-dominated (61.3%) to
an IgG-dominated (81.6%) response (Fig. 1 B). However,
poly(I:C) did not similarly enhance the magnitudes of all IgG
subclasses but, rather, had the most striking effect on the
NP-specific IgG2c response by accelerating the kinetics and
increasing the magnitude of this isotype (Fig. 1, A and B).
Relative to other IgG isotypes, IgG2c is the least abundant
isotype produced during the NP-Ficoll response in the
absence of poly(I:C) (Fig. 1 B; Mongini et al., 1981, 1984).
Enhancement of the IgG2c response by poly(I:C) was dose
dependent (Fig. S1 A) and, importantly, not a result of
IFN- drives FO B cell TI-2 responses | Swanson et al.
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Bachmann and Zinkernagel, 1997; Fehr et al., 1998). In con
trast to TI antigens, TD antigens are generally monomeric
soluble proteins that display single or few epitopes to antigenspecific B cells and require cognate T cell help for induction
of highly specific antibody responses generated through ger
minal center reactions.
Although not absolute, a general division of labor is also
acknowledged between B cell subsets and the response to
TI-2 and TD antigens. B1 and MZ B cell subpopulations
have been considered to be primarily responsible for the
antibody response to TI-2 antigens (Fagarasan and Honjo,
2000; Martin et al., 2001; Balázs et al., 2002), whereas FO
B cells dominate antibody responses to soluble protein TD
antigens. In accord with generating rapid antibody responses,
MZ and B1 B cells have lower thresholds for activation com
pared with FO B cells and are physically poised at sites either
in tissues or at the blood–lymphoid interface that facilitates
these early responses (Martin and Kearney, 2002). B1 and
MZ B cells are described as innate B cells in that they express
a restricted repertoire of germline-encoded BCRs with poly
reactive specificities (Bendelac et al., 2001). Responding MZ
B cells produce antigen-specific antibody at extrafollicular
splenic sites early during the antibody response that is low af
finity and predominantly IgM but also includes limited IgG
subclasses. Although evidence exists that MZ B cells can also
mount TD responses and initiate germinal center reactions
(Song and Cerny, 2003; Phan et al., 2005), the ability of FO
B cells to directly participate in rapid extrafollicular TI-2 anti
body responses is minor (Ron and Sprent, 1985; Goud et al.,
1988; Liu et al., 1988).
Characterization of the TI-2 antibody response has
predominantly relied on hapten-coupled carbohydrates
as model antigens. However, physiological TI-2 antigens
would rarely be encountered in isolation but, rather, are
typically associated with pathogen-associated molecular
patterns (PAMPs) recognized by pattern recognition re
ceptors (PRRs; Janeway, 1989; Snapper, 2006). TLRs are
one family of innate immune PRRs that have been shown
to enhance the antibody response (Coutinho et al., 1974;
Seppälä and Mäkelä, 1984; Sen et al., 2005; Heer et al.,
2007; Rubtsov et al., 2008; Eckl-Dorna and Batista, 2009).
However, whether this regulation is physiologically rele
vant has been controversial (Pasare and Medzhitov, 2005;
Gavin et al., 2006).
A major consequence of signaling by many PRRs is the
rapid elaboration of inflammatory type I IFN cytokines
(Baccala et al., 2007; McCartney and Colonna, 2009), and
many viral and bacterial infections lead to IFN-/ produc
tion (Bogdan, 2000; Mancuso et al., 2009). Type I IFN has been
previously characterized to modulate antibody production
both in vitro and in vivo, including promoting class-switch
recombination and polarizing antibody responses toward
IgG2a/c production (Finkelman et al., 1991; Le Bon et al.,
2001, 2006; Coro et al., 2006; Heer et al., 2007). How IFN/ acts to effect these changes in humoral immunity is not
well established, nor is whether the type I IFN produced as a
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nonspecific antibody production by polyclonally activated B
cells (Fig. S1, B and C). Poly(I:C) alone did not induce either
NP-specific IgG2c or total antigen nonspecific IgG2c. These
results were confirmed by measuring the total IgG2c levels
after immunization with NP-Ficoll ± poly(I:C) (Fig. S1 C).
Although poly(I:C) was found to increase total IgG2c serum
levels on day 7, this increase was fully accounted for by the
increase in NP-specific IgG2c at the same time point (Fig. 1 A).
Together, these results negate a role for polyclonal IgG2c
antibody production and verify that poly(I:C) enhances the
TI-2 antibody response by an antigen-specific mechanism.
It is of note that IgG2c (IgG2a in Igha expressing mouse
strains) is not only the predominant Ig isotype generated
in antiviral antibody responses (Coutelier et al., 1987) but is
also considered a highly effective antipathogen Ig isotype
(Nimmerjahn and Ravetch, 2005, 2008). Thus, we restricted
our subsequent focus to understanding the mechanism by
which poly(I:C) altered the production of this IgG2c response.
Poly(I:C) augments the long-lived IgG2c TI-2 antibody response
NP-Ficoll elicits relatively long-lived serum NP-specific
antibody responses in the absence of adjuvants (García de
Vinuesa et al., 1999; Obukhanych and Nussenzweig, 2006). We
examined the adjuvant efficacy of poly(I:C) on this response
and found that poly(I:C) significantly enhanced NP-specific
IgG2c antibody levels at all time points evaluated (Fig. 2 A).
However, although the levels of long-lived antigen-specific
antibody were considerably increased, this did not result from
an increased longevity of the antigen-specific IgG2c antibody
response as the rate of decline of NP-specific IgG2c antibodies
was similar regardless of poly(I:C) (Fig. 2 A).
Poly(I:C) facilitates an extrafollicular and low-affinity IgG2c
antibody response to NP-Ficoll
TI-2 antigens typically elicit a rapid extrafollicular antibody
response with limited isotype class switching and without
JEM VOL. 207, July 5, 2010

somatic hypermutation (MacLennan et al., 2003). Given the
rapid nature of the IgG2c antibody response induced by
poly(I:C) to NP-Ficoll, we tested whether this would like
wise be a low-affinity extrafollicular response.
The primary antibody response to NP-Ficoll is dominated
by Ig+ NP-specific antibodies (Tesch et al., 1984), thus
we used Ig expression as a surrogate for NP-specific ASCs
(Claassen et al., 1986; Jacob et al., 1991; García de Vinuesa
et al., 1999; Shih et al., 2002). NP-Ficoll alone elicited Ig+
IgM–expressing ASCs localized to extrafollicular foci in the
bridging channel of the red pulp (Fig. 2 B) as previously re
ported (Claassen et al., 1986; García de Vinuesa et al., 1999;
Shih et al., 2002). NP-Ficoll + poly(I:C) induced not only
extrafollicular Ig+ IgM–expressing ASCs but also Ig+ IgG2c–
expressing ASCs within extrafollicular foci. Additionally, Ig+
plasma cells that lacked IgM or IgG2c expression (Fig. 2 B)
were also observed with poly(I:C) and are likely to be NPspecific IgG3-producing ASCs, as this isotype comprised a
significant amount of the response (Fig. 1 B).
The relative affinity of poly(I:C)-induced NP-specific
IgG2c antibodies was also measured and found to be com
prised of relatively low-affinity antibodies, which is similar to
that produced in response to NP-Ficoll alone (Fig. 2 C). In
addition, this relative affinity did not increase with time indi
cating the absence of affinity maturation (Fig. 2 C). Thus, we
show that poly(I:C) promotes a rapid IgG2c class-switched
TI-2 antibody response characterized by both extrafollicular
antibody secretion and low-affinity antibodies.
Both splenic and lymph node B cells participate in the poly(I:C)elicited IgG2c antibody response to NP-Ficoll
Measuring the frequency of splenic NP-specific IgG2c ASCs
after immunization with poly(I:C) revealed a relative increase
in the frequency of splenic NP-specific B cells that differ
entiated into IgG2c ASCs (Fig. 3 A). In accordance with anti
body levels in serum (Fig. 1 A), poly(I:C) also promoted a
1487
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Figure 1. Poly(I:C) enhances the anti
body response to a model TI-2 antigen.
(A) C57BL/6 mice were immunized with 5 µg
NP-Ficoll alone or 5 µg NP-Ficoll + 100 µg
poly(I:C) and serum NP-specific IgM, IgG3, and
IgG2c antibodies were measured in preimmune
(day 0 [d0]), day 4, and day 7 after immunization sera. Symbols represent individual mice,
and horizontal bars indicate geometric mean.
Data were combined from two independent
experiments with five mice per group per
experiment. *, P ≤ 0.005. (B) Total serum NPspecific IgG2c, IgG3, IgG2b, IgG1, and IgM were
measured 7 d after immunization with NPFicoll ± poly(I:C). Data represent geometric
means calculated from data combined from
two independent experiments, with five mice
per group per experiment. Geometric means
from NP-specific IgM, IgG3, and IgG2c responses
were the same as those represented in A.

Figure 2. Poly(I:C) promotes a long-lived, extrafollicular, and
low-affinity IgG2c antibody response to NP-Ficoll. (A) C57BL/6 mice
were immunized with either NP-Ficoll alone or with poly(I:C) and serum
NP-specific IgG2c antibodies measured before and at the indicated days
after immunization. Data are expressed as the geometric mean ± SEM.
Results shown are from one representative experiment of two independent experiments performed. *, P ≤ 0.002. (B) Histological spleen sections
from C57BL/6 mice 7 d after immunization with NP-Ficoll or NP-Ficoll +
poly(I:C). Top panels show sections stained for Ig, IgM, and IgG2c. B cell
follicles within the white pulp were revealed by IgM staining to provide
orientation for the general lymphoid architecture. Top panels are 10×
original magnification with enlarged areas within white outlined boxes
represented in middle and bottom panels. Bottom panels depict only
green Ig+ ASCs and white arrows identify IgG2c ASCs. Bars, 50 µm. Data
are representative of two independent experiments. (C) Relative affinity of
NP-specific IgG2c antibodies was determined as the binding ratio of NP4/
NP16 and was measured by ELISA. Sera samples were analyzed from mice
at 7, 14, and 31 d after immunization with NP-Ficoll or NP-Ficoll + poly(I:C).
Results were combined from two independent experiments with four
to eight mice per immunization group. Data are expressed as the
1488

MZ B cells are not required for the IgG2c antibody
responses to NP-Ficoll + poly(I:C)
B1 and MZ B cells are considered the major contributors
to the TI-2 antibody response (Fagarasan and Honjo, 2000;
Martin et al., 2001). However, with regards to NP-Ficoll in
particular, MZ B cells have been shown to be predominantly
responsible for the TI-2 antibody response (Otipoby et al.,
1996; Guinamard et al., 2000; Samardzic et al., 2002; Shih
et al., 2002). Because MZ B cells are restricted to the spleen
in rodents, we addressed whether MZ B cells contributed to
the poly(I:C)-induced IgG2c response by splenectomy and
immunization with NP-Ficoll ± poly(I:C). As previously re
ported (Amlot et al., 1985), splenectomized mice mounted
significantly reduced NP-specific IgM responses at days 4 and
7 after immunization with NP-Ficoll compared with shamoperated animals and irrespective of poly(I:C) (Fig. 3 C).
Likewise, at day 7 the antigen-specific IgG2c response to
NP-Ficoll alone was diminished approximately sevenfold in
splenectomized mice (Fig. 3 C). However, in the presence of
poly(I:C) there was only a twofold reduction in the NP-specific
IgG2c response measured in asplenic mice as compared with
controls (Fig. 3 C). These data confirm MZ B cells are largely
responsible for the NP-Ficoll IgM response and further show
this is true in the presence of poly(I:C). Conversely, the small
IgM and IgG2c antibody responses generated in asplenic
mice highlight a minor role for FO B cells in the NP-Ficoll
TI-2 response (Ron and Sprent, 1985; Goud et al., 1988; Liu

arithmetic mean ± SEM. The NP-specific IgG2c mAb S43-10 was used as a
positive control for a high-affinity binding antibody.
IFN- drives FO B cell TI-2 responses | Swanson et al.
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concomitant decline in the frequency of splenic NP-specific
IgM ASCs. Furthermore, no significant differences were mea
sured in the frequency of either NP-specific IgG2c or IgM
ASCs in the bone marrow of mice regardless of poly(I:C)
immunization (unpublished data).
Given the accelerated kinetics of the IgG2c response in
duced by poly(I:C), we initially considered that MZ B cells
destined to produce IgM were subverted to class switch to
IgG2c during this TI-2 response. However, antigen-specific
IgG2c ASCs were also present in the lymph nodes of mice
immunized with NP-Ficoll + poly(I:C) and were virtually
absent in mice immunized with antigen alone (Fig. 3 B). As
MZ B cells do not normally recirculate in rodents (Gray et al.,
1982; Kumararatne et al., 1982), the presence of lymph node
NP-specific IgG2c ASCs indicated that a non-MZ popula
tion contributed at least partially to the poly(I:C)-induced
IgG2c response. Although the capacity of lymph node B cells
to respond to TI-2 antigens has been shown (Ron and Sprent,
1985; Goud et al., 1988; Liu et al., 1988; Vinuesa et al., 2003),
this response is limited with respect to other B cell subsets
(Martin et al., 2001; Balázs et al., 2002). Thus, our data sug
gest that innate signals augment the TI-2 antibody response
in part via enhanced production of antigen-specific IgG2c by
lymph node B cells.

Ar ticle

et al., 1988; Vinuesa et al., 2003). Collectively, our findings
suggest that in the presence of poly(I:C), a B cell population
distinct from MZ B cells is the predominant source of NPspecific IgG2c.
JEM VOL. 207, July 5, 2010

To provide further support for this notion, we used a
second model in which the MZ B cell population was selec
tively depleted by in vivo treatment with anti-integrin (4/L)
antibodies (Lu and Cyster, 2002) while FO B cells were left
1489
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Figure 3. Poly(I:C) elicits recruitment of
FO B cells to participate in the enhanced
IgG2c TI-2 antibody response. (A) Frequency of splenic NP-specific IgM and IgG2c
ASCs as measured by ELISPOT 7 d after immunization with either NP-Ficoll alone or NPFicoll + poly(I:C). Each symbol represents an
individual mouse and horizontal bars indicate
either mean (IgM) or geometric mean (IgG2c).
Data was combined from four independent
experiments with three to five mice per group
per experiment. *, P < 0.0001. (B) ELISPOT of
NP-specific IgG2c ASCs in lymph nodes from
C57BL/6 mice at 7 d after immunization with
either NP-Ficoll alone or NP-Ficoll + poly(I:C).
Lymph nodes were pooled from three immunized mice. Data was from two representative
samples shown for each immunization condition. Data was from one experiment of two
independent experiments performed. (C) Wildtype splenectomized or sham-operated mice
were immunized with NP-Ficoll alone or NPFicoll + poly(I:C) and serum NP-specific IgM
and IgG2c antibody measured at days 0, 4,
and 7 after immunization. Data are expressed
as the geometric mean + SEM. Results were
combined from two independent experiments
with four to six mice per group per experiment. *, P < 0.05. (D) C57BL/6 mice were
treated with 100 µg each of anti-4 + antiL antibodies or isotype control antibodies.
7 d after antibody injection, mice were immunized with either NP-Ficoll alone or NP-Ficoll +
poly(I:C) and serum NP-specific IgM and
IgG2c antibody responses measured at the
indicated times. Data are expressed as the
geometric mean + SEM. Results are from one
experiment with four to five mice per group.
*, P < 0.05. (E) Frequency of NP-specific IgG2c
splenic ASCs measured from antibody-treated
wild-type mice. Symbols are the same as
those described in D and represent the frequency measured from individual animals.
Horizontal bars indicate geometric mean.
Results are from one experiment with four
mice per group. (F) Representative flow cytometric analysis of CD21 and CD23 expression
in spleen and lymph node of BL6-IghB1-8/B1-8
(Igha) mice. Total lymph node cells (5 × 107)
were transferred to C57BL/6 (Ighb) mice and
immunized 1 d later. The presence and phenotype of transferred Igha+ lymph node B cells
within a splenic FO B cell gate (CD21int CD23high) and MZ B cell gate (CD21high CD23low) in one representative recipient 1 d after transfer is shown. Recipient mice were immunized with either NP-Ficoll alone or NP-Ficoll + poly(I:C) and NP-specific IgG2a antibodies measured in sera at the indicated time
points. Antibody concentrations are shown as relative titers and data are expressed as the geometric mean ± SEM. Results shown from one representative
experiment of two independent experiments performed, with four mice per group. n.d., not detected. *, P ≤ 0.0003.

Poly(I:C) promotes FO B cells to participate in the IgG2c
class-switched TI-2 antibody response
Our findings indicated that FO B cells contributed signifi
cantly to the poly(I:C)-induced NP-Ficoll response, although
the capacity of lymph node B cells to contribute to the TI-2
antibody response has been considered minimal (Ron and
Sprent, 1985; Goud et al., 1988; Liu et al., 1988). To directly
examine if FO B cells mounted poly(I:C)-induced IgG2c
antibody responses to NP-Ficoll in vivo, we adoptively trans
ferred lymph node cells from IghB1-8/B1-8 (Igha) mice (Sonoda
et al., 1997) into recipients and immediately assessed their
ability to respond to NP-Ficoll ± poly(I:C). The B cells
within the lymph node were phenotypically homogenous
as CD21int CD23high FO B cells and maintained this pheno
type after adoptive transfer (Fig. 3 F). The B1-8 IgH chain con
fers NP-specificity when paired with an Ig light chain (Jack
et al., 1977; Reth et al., 1978; Bothwell et al., 1981), effec
tively increasing the NP-specific cells to 5% of the B cell
population (unpublished data). Before immunization, the
adoptively transferred FO B cells comprised 2.5% of the
total splenic B cell compartment, and thus 0.1% of the
B cells in the recipient were IgMa (B1-8) and NP specific
(unpublished data).
After immunization with NP-Ficoll alone, adoptively
transferred FO B cells generated a relatively weak and de
layed NP-specific IgG2a response (Fig. 3 F). As predicted,
Figure 4. The TI-2 IgG2c response
induced by poly(I:C) is not mediated by
B cell–intrinsic TLR3 signaling. (A) NPspecific IgG2c responses in wild type, Tlr3/,
Mda5/, and Tlr3/ Mda5/ mice measured from sera collected preimmunization
(day 0) and at 7 d after NP-Ficoll + poly(I:C)
immunization. Symbols represent individual
mice, and horizontal bars indicate geometric
mean. Shown is one representative of two
independent experiments performed, with
four to five mice per group. *, P < 0.05.
(B) NP-specific IgG2c/a antibody responses
in mixed bone marrow chimeras 7 d after
immunization with NP-Ficoll + poly(I:C).
A mixture of bone marrow cells from B6.C20
(Igha) and Tlr3/ (Ighb; experimental chimeras; filled) or B6.C20 and wild-type C57BL/6
(Ighb; control chimeras; open) was adoptively
transferred to lethally irradiated B6.C20 hosts.
8 wk after reconstitution, chimeras were immunized and NP-specific antibody measured
in preimmune and day-7 sera. Reconstitution
frequencies of IgMa- and IgMb-expressing
B cells were measured as described in the
Materials and methods and found to be
equivalent between both experimental and
control chimeras. Symbols represent individual chimeric mice, and horizontal bars
indicate geometric mean. Data were combined
from two independent experiments with five
to six mice per group. n.d., not detected.
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intact (Belperron et al., 2005, 2007). MZ B cells are retained
within the MZ by integrin adhesion and are released into
circulation by administration of anti-integrin mAbs (Fig. S2,
A and B; Lu and Cyster, 2002). Consistent with the splenec
tomy data, depletion of MZ B cells led to a large reduction in
the NP-specific IgM response to NP-Ficoll ± poly(I:C) at 4 d
after immunization as compared with controls (Fig. 3 D).
Although a similar reduction in NP-specific IgM was not ob
served at day 7 after immunization, this time point coincided
with the return of MZ B cells to the spleen after integrin
treatment and MZ B cell depletion (Fig. S2). In contrast,
mice depleted of MZ B cells generated equivalent poly(I:C)elicited NP-specific IgG2c responses at all time points evalu
ated (Fig. 3 D). Although these results do not formally
eliminate a role for MZ B cells in the poly(I:C)-induced
IgG2c response, they illustrate that MZ B cells do not make
a significant contribution to this response.
It remained possible that MZ B cells relocated outside the
spleen but were still responsive to poly(I:C) and able to gen
erate NP-specific IgG2c from this extrasplenic site. How
ever, this was excluded as the frequency of splenic NP-specific
IgG2c ASCs generated upon immunization with NP-Ficoll
+ poly(I:C) was the same regardless of MZ B cell depletion
(Fig. 3 E). These findings strongly suggest that FO B cells are
the predominant source of the poly(I:C)-induced IgG2c
antibody response to the TI-2 antigen NP-Ficoll.
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Poly(I:C)-induced NP-specific IgG2c does not require TLR3
signaling by B cells
As a dsRNA analogue, poly(I:C) is recognized by both TLR3
and MDA5 PRRs in vivo (Alexopoulou et al., 2001; Gitlin
et al., 2006; Kato et al., 2006). To assess the in vivo contribu
tion of these PRRs in the poly(I:C)-induced IgG2c antibody
response, Tlr3/ and Mda5/ single and compound mutants
were immunized with NP-Ficoll + poly(I:C). These results re
vealed modest but significant reductions in NP-specific IgG2c
in the absence of either TLR3 or MDA5 that were additive in
Tlr3/ Mda5/ double mutants (Fig. 4 A). The combined

reduction observed in the double-deficient mice implicates
both TLR3 and MDA5 in the recognition of poly(I:C) and sub
sequent induction of a class-switched IgG2c B cell response.
The requirement for direct TLR signaling by B cells dur
ing antibody responses has been the subject of recent debate
(Pasare and Medzhitov, 2005; Gavin et al., 2006; Barr et al.,
2007, 2009; Jegerlehner et al., 2007; Meyer-Bahlburg et al.,
2007). Thus, we next questioned whether B cell–autonomous
TLR3 signaling was required for the poly(I:C)-induced NPFicoll IgG2c response. To address this, we generated mixed
bone marrow chimeras whereby wild-type (B6.C20-Igha)
and either Tlr3/ or Tlr3+/+ (Ighb) B cells were juxtaposed
in direct competition with each other in recipient mice, and
we measured the capacity of both populations to generate an
IgG2a/c antibody response to NP-Ficoll + poly(I:C) (Fig. 4 B).
In these chimeras, TLR3/ (Ighb) B cells mounted equiv
alent NP-specific IgG2c responses upon immunization with
NP-Ficoll + poly(I:C) as compared with wild-type (C57BL/
6-Ighb) B cells in control chimeras (Fig. 4 B). These results
demonstrate that direct TLR3 signaling by B cells is not re
quired for poly(I:C)-induced TI-2 IgG2c responses. Further
more, these findings suggest that downstream secondary
innate cytokine signals induced by PRR signaling may
suffice in promoting B cell IgG2c antibody responses.
Figure 5. Poly(I:C) induction of IgG2c
requires type I IFN receptor signaling by
B cells. (A) NP-specific IgM and IgG2c responses
in wild-type and Ifnar1/ mice measured from
sera collected at days 0 and 7 after immunization with NP-Ficoll + poly(I:C). Symbols represent
individual mice, and bars represent geometric
means. Data were combined from two independent experiments with three to five mice per
group per experiment. *, P ≤ 0.005. (B) C57BL/6
mice were immunized with 5 µg NP-Ficoll alone
or in the presence of 100 µg Pam3CSK4 (TLR1/2),
100 µg poly(I:C) (TLR3), 100 µg 3M-012 (TLR7),
or 8 × 105 U rIFN-11. NP-specific IgG2c responses were measured from sera collected
preimmune (day 0) and at 7 d after immunization. Symbols represent individual mice, and
horizontal bars indicate geometric mean. Shown
is one representative of two independent experiments performed, with four mice per group.
(C) Mixed bone marrow chimeras were generated
as described in Fig. 2 B, except that experimental
chimeras were generated from the transfer of
Ifnar1/ (Ighb) + B6.C20 (Igha) bone marrow.
After reconstitution, chimeric mice were immunized with NP-Ficoll + poly(I:C) and NP-specific
IgMa, IgMb, IgG2a, and IgG2c serum antibody
responses measured preimmune (day 0) and at 7
d after immunization. Symbols represent individual mice, and horizontal bars indicate geometric mean. Representative data are from one
experiment shown of two independent experiments performed, with four mice per group. n.d.,
not detected. *, P < 0.05.
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poly(I:C) markedly enhanced both the magnitude and kinet
ics of the NP-specific IgG2a response produced from FO B
cells in vivo (Fig. 3 F) and similar to that elicited by poly(I:C)
in wild-type mice (Fig. 1 A). Similar findings were found
when fivefold fewer (107) LN cells were transferred (unpub
lished data). These findings directly demonstrate that FO B
cells are able to generate IgG2c/a antibody responses to a TI-2
antigen and, more importantly, show that this response is
both accelerated and amplified by poly(I:C). Collectively,
these results reveal that FO B cells provide a rapid and robust
innate-like IgG2c antibody response to a TI-2 antigen elic
ited by poly(I:C).

Type I IFN mediates poly(I:C)-induced antigen-specific
IgG2c during the TI-2 antibody response
Both TLR3 and MDA5 dsRNA-sensing receptors are
capable of recognizing poly(I:C) to induce a rapid type I IFN
response (Alexopoulou et al., 2001; Gitlin et al., 2006; Kato
et al., 2006; Longhi et al., 2009). Given the accelerated IgG2c
response to poly(I:C), we assessed the contribution of type I
IFN to this response by immunizing Ifnar1/ mice. These
results showed that the NP-specific IgG2c response to
poly(I:C) immunization was reduced 90% in Ifnar1/ mice
compared with wild type (Fig. 5 A) and inversely mirrored
by a modest but significant increase in the NP-specific IgM
response over wild-type controls (Fig. 5 A). These findings
demonstrate that type I IFN signaling is necessary for efficient
induction of the TI-2 IgG2c antibody response promoted by
poly(I:C).
Type I IFN is an early hallmark of the antiviral innate im
mune response initiated from the recognition of viral PAMPs.
Thus, we predicted that the instruction to class switch to
IgG2c during the TI-2 antibody response would be a general
property of all PAMPs capable of stimulating endogenous
type I IFN production. To test this, we immunized mice
with a representative group of TLR agonists known to stim
ulate type I IFN (TLR7 agonist, 3M-012; Gorden et al.,
2005) or not (TLR1/2 agonist, Pam3CSK4; Longhi et al.,
2009) and measured the IgG2c antibody response elicited
to NP-Ficoll. As predicted, mice immunized with a type I
1492

IFN-inducing TLR7 agonist produced NPspecific IgG2c antibody responses similar to that
induced by poly(I:C) (Fig. 5 B). Conversely, the
Pam3CSK4 TLR1/2 agonist did not promote
NP-specific IgG2c above levels seen with antigen
alone (Fig. 5 B). These findings indicate that type
I IFN-inducing adjuvants promote class-switching
to IgG2c during the TI-2 antibody response. Fur
thermore, these results are consistent with results
showing that type I IFN augments particular iso
types during the B cell antibody response to soluble protein
antigens and viruses (Finkelman et al., 1991; Le Bon et al.,
2001; Coro et al., 2006; Heer et al., 2007).
We next considered whether we could bypass the re
quirement for signaling through PRRs altogether by directly
providing exogenous type I IFN during immunization. Mice
immunized with NP-Ficoll and a single administration of
rIFN- were found to mount significantly higher levels of
NP-specific IgG2c than NP-Ficoll alone (Fig. 5 B). Although
the magnitude of the IgG2c response elicited by rIFN- im
munization was reduced compared with poly(I:C) immuni
zation, it was nevertheless notable that a single treatment
induced a considerable IgG2c antibody response after 1 wk.
Type I IFN receptor expression by B cells is required
for the IgG2c TI-2 antibody response
To address whether expression of the type I IFN receptor
was required by B cells for the poly(I:C)-induced IgG2c TI-2
response antibody response, Ifnar1/ B cells were evaluated
in mixed bone marrow chimeras in direct competition with
wild-type B cells. Antibody responses by Ifnar1/ (Ighb) B cells
or wild-type B6 (Ighb) B cells were measured as NP-specific
IgMb and IgG2c, whereas competing wild-type (B6.C20-Igha)
responses in both experimental and control chimeras were
detected as NP-specific IgMa and IgG2a (Fig. 5 C).
Upon immunization with NP-Ficoll + poly(I:C), wildtype (B6-Ighb) B cells in control chimeras mounted significant
IFN- drives FO B cell TI-2 responses | Swanson et al.
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Figure 6. IFN- induces BCR-stimulated FO B cells
to up-regulate CD69 to a greater extent than MZ
B cells. (A) Histograms represent flow cytometric analysis
of IFNR1 surface expression on CD21int CD23high FO B
cells and CD21high CD23low MZ B cells isolated from naive
wild-type mice. Isotype control antibody staining for both
FO (shaded light gray) and MZ (dashed line) B cells is
provided. Data are representative from two independent
experiments. (B–D) FO and MZ B cells were sorted to ≥94%
purity from naive C57BL/6 mice and separately incubated
with the indicated stimuli in vitro for 6 or 10 h. After
stimulation, surface expression of CD69 (6 h) or CD86
(10 h) was subsequently assessed in both B cell populations
by flow cytometry and data depicted as histograms. The
following stimuli and doses were used: (B) rIFN- at 1, 10,
or 100 U/ml; (C) rIFN- at 1 U/ml and anti-IgM F(ab)2 at
10 µg/ml; (D) LPS at 10 µg/ml. Med, medium. Data are
representative from at least two independent experiments.
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IFN- acts selectively on BCR-activated FO B cells
to increase CD69 expression
FO and MZ B cells express similar levels of the type I IFN
receptor (Fig. 6 A), excluding differential receptor expression
as an origin for the dominant FO B cell response to type I IFNpromoting adjuvants. Thus, we predicted that type I IFN
differentially influenced FO B cells relative to MZ B cells.
Type I IFN can directly activate B cells in vitro (Morikawa
et al., 1987; Braun et al., 2002; Coro et al., 2006; Kamphuis
et al., 2006; Shiow et al., 2006) and in vivo (Chang et al.,
2007; Coro et al., 2006; Shiow et al., 2006). Thus, we
assessed the ability of IFN- to activate either FO or MZ B
cells and found that both populations displayed similar sensi
tivity and kinetics to recombinant IFN as measured by induc
tion of surface expression of CD69 and CD86 activation
antigens (Fig. 6 B and not depicted).
We next questioned whether FO and MZ B cells might
differ in their response to IFN- stimulation in the context
of BCR-mediated activation similar to the situation during
an antibody response. Concomitant treatment of FO B cells
with anti-IgM and suboptimal levels of IFN- led to CD69
expression to levels greater than those detected with antiIgM stimulation alone (Fig. 6 C). In contrast, anti-IgM
treatment of purified MZ B cells failed to increase CD69
expression to any appreciable level and, importantly, this
expression was not enhanced by concomitant IFN- treat
ment (Fig. 6 C). The inability of anti-IgM to induce CD69
expression on MZ B cells was not true of all activation
markers as anti-IgM ± IFN- increased CD86 expression
similar to FO B cells (Fig. 6 C). Furthermore, MZ B cells
exhibited increased sensitivity to LPS activation as mea
sured by CD86 expression (Fig. 6 D) as previously shown
(Oliver et al., 1999).
JEM VOL. 207, July 5, 2010

Overall, these data demonstrate that IFN- selectively
acts on BCR-stimulated FO, but not MZ, B cells to elevate
CD69 surface expression. Type I IFN-mediated surface
expression of CD69 is inversely correlated with S1P1 chemo
attractant receptor responsiveness (Shiow et al., 2006),
suggesting that selective CD69 expression by antigenexperienced FO B cells could alter the trafficking of these
cells during a response.
DISCUSSION
Study of B cell antibody response to hapten model antigens
over the last several decades has provided considerable insight
into how humoral immunity deals with different types of
antigens. In particular, the reductionist nature of these model
antigens facilitated our understanding of how different B cell
subpopulations respond to distinct antigens. However, it is
now evident that extrapolating from these studies is limited
with respect to modeling humoral immunity to physiological
pathogens. Pathogens such as viruses and bacteria not only
present TI and TD antigens to B cells but also display a vari
ety of PAMPs capable of alerting the innate immune system.
This study addresses how these PAMPs influence humoral
immunity to TI-2 antigens.
The most dramatic changes elicited by poly(I:C) to the
TI-2 antibody response were measured in the acceleration
of the kinetics and overall increase in the magnitude of the
antigen-specific IgG2c response. Heightened production of
IgG2c is significant, as this isotype is the most efficient IgG
subclass for anti-pathogen FcR-mediated effector functions
(Nimmerjahn and Ravetch, 2005) and has long been recog
nized as the predominant isotype elicited by viral infections
(Coutelier et al., 1987). Thus, these findings support the no
tion that PAMPs polarize antibody responses to those iso
types best suited to deal with particular pathogens (Janeway,
1989). We further show that during the TI-2 antibody re
sponse, poly(I:C) promotes a persistence of elevated levels of
antigen-specific IgG2c serum antibody, which are similar to
those previously shown for TD antibody responses (Le Bon
et al., 2001). The durability of this enhanced response has
implications for vaccine design given the importance of neu
tralizing antibody concentration in providing efficacious
antiviral protective immunity (Bachmann and Zinkernagel,
1997; Bachmann et al., 1997; Pulendran, 2009).
Generally, pathogen-specific antibody responses divert
from characterized hapten-specific responses, as they are typ
ically faster and elicit IgG isotypes earlier than anti-hapten
responses (Bachmann and Zinkernagel, 1997). We show that
including a type I IFN-inducing PRR agonist with the NPFicoll TI-2 antigen results in a rapid anti-hapten IgG2c re
sponse. This class-switched anti-hapten response more closely
reflects previously characterized antiviral and antimicrobial
antibody responses with regard to kinetics, isotype specificity,
and extrafollicular antibody production, illustrating the ap
plicability of these studies to model pathogens. For instance,
among the many arms of the influenza antibody response,
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NP-specific IgMb and IgG2c antibody responses (Fig. 5 C).
As predicted from immunization of IFNR1/ mice
(Fig. 5 A), Ifnar1/ (Ighb) B cells also produced an NP-specific
IgMb antibody response (Fig. 5 C). In contrast, Ifnar1/ (Ighb)
B cells did not generate any significant NP-specific IgG2c
antibody (Fig. 5 C). Moreover, wild-type (B6.C20-Igha)
B cells in competition with IgMb-expressing B cells in both
sets of chimeras made comparable NP-specific IgMa and
IgG2a antibody responses (Fig. 5 C), further eliminating a
role for non–B cell hematopoietic populations and indicating
a B cell–autonomous defect. This impaired ability of Ifnar1/
B cells to class switch to IgG2c was not a result of abnormal
B cell development, as Ifnar1/ mice have normal composi
tions of mature splenic B cell compartments (Le Bon et al.,
2006; Green et al., 2009).
These data show that Ifnar1/ B cells contribute normally
to TI-2 IgM responses but that in the presence of type I IFN–
inducing PAMPs such as poly(I:C), they are unable to generate
antigen-specific IgG2c TI-2 antibody response. This establishes
an in vivo role for type I IFN receptor signaling by FO B cells
in directly promoting the production of the antiviral IgG2c iso
type and, thus, enhancing the B cell antibody response.
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in TLR3/ MDA5/ double knockout chimeric mice
(Longhi et al., 2009), which is similar to our findings with the
B cell antibody response. As RIG-I is also a cytosolic PRR
capable of recognizing low-molecular-wt poly(I:C) to signal
type I IFN production (Kato et al., 2008), we envision that
this dsRNA sensor is likely responsible for the type I IFN
that promotes a modest increase in NP-specific IgG2c in the
double mutants. Ultimately, our data demonstrate that non–
TLR-innate signals, such as type I IFN, can substitute for
TLR sensing of non-self to augment antibody responses. This
redundancy in the recognition of poly(I:C) by multiple dsRNAsensing receptors highlights the importance of IFN-/ as a
global non-self warning signal for enhancing the efficiency of
anti-pathogen antibody responses. Indeed, it has been noted
that all vertebrates examined have immune systems com
prised by T and B lymphocytes and genes encoding IFN-
and IFN- (Stetson and Medzhitov, 2006), suggesting that
the type I IFN-mediated innate response is closely associated
with adaptive immunity.
For humoral immunity, type I IFN elaborated during
antiviral responses promotes IgG2a/c antibody production
in vivo (Finkelman et al., 1991; Heer et al., 2007). However,
the role for B cell–intrinsic signaling by type I IFN to directly
instruct IgG2c class switching in vivo is unclear. Specifically,
signaling through the IFN-R expressed by B and T cells has
been shown to enhance IFN-–mediated IgM and IgG re
sponses to soluble proteins (Le Bon et al., 2006). In opposi
tion, direct IFN-R signaling by B cells has been found to be
unnecessary for the antiviral IgG2c response during acute in
fluenza infection (Coro et al., 2006). Using a chimeric B cell
competition model, we demonstrate that B cell–autonomous
IFN-R signaling does induce IgG2a/c switching in vivo
during systemic type I IFN responses, such as that elicited by
poly(I:C). The discordance between our findings and other
studies likely illustrates the complexity of additional inflam
matory cytokines, beyond type I IFN, that are elicited during
viral infections and that also regulate the instruction to switch
between Ig subclasses (Coro et al., 2006).
A potential mechanism to account for the type I IFNinduced response from FO B cells is suggested by the ability
of type I IFN to modulate CD69 expression on FO B cells.
It has been shown that IFN-induced CD69 surface expression
inhibits lymphocyte egress from lymphoid organs by the
concomitant loss of sphingosine-1-phosphate responsiveness
(Shiow et al., 2006). In accord with this, virus-induced IFN/ also causes accumulation of circulating FO B cells to re
gional lymph nodes early during antiviral responses (Chang
et al., 2007). The enhanced response by FO B cells to upregulate CD69 in response to IFN- and BCR-mediated
activation would presumably ensure that these normally
recirculating B cells would be retained within secondary
lymphoid organs where they can receive further noncognate
secondary signals necessary for TI-2 antibody responses
(Chang et al., 2007). In addition, as TI-2 antigens would
likely be associated with TD antigens within a pathogen, the
IFN- drives FO B cell TI-2 responses | Swanson et al.
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a localized IgG2c extrafollicular B cell antibody response is de
tectable within a few days in mediastinal lymph nodes after
intranasal infection (Coro et al., 2006). Similarly, vesicular
stomatitis virus has been demonstrated to have a highly or
ganized antigenic capsid capable of eliciting TI antibody
responses (Bachmann et al., 1995) while simultaneously
inducing an early isotype-switched antibody response
(Bachmann et al., 1996). These early class-switched responses
are not exclusive to antiviral responses, as Salmonella typhimurium
likewise promotes an extrafollicular IgG2c switched plasma
cell response detectable 4 d after infection (Cunningham et al.,
2007). Thus, the common feature of this rapid and highly
efficient IgG subclass elicited to both major anti-pathogen
responses further highlights the physiological and biological
relevance of our findings.
Mature naive murine B cells constitutively express tran
scripts for the majority of TLRs (Barr et al., 2007; Genestier
et al., 2007; Gururajan et al., 2007), and mature B cells can
respond to TLR3 signaling in vitro (Alexopoulou et al.,
2001). The requirement for direct TLR signaling by B cells
during antibody responses has been controversial. In particu
lar, previous studies have demonstrated a B cell–intrinsic
requirement for TLR signaling in the generation of B cell
antibody responses (Pasare and Medzhitov, 2005; Jegerlehner
et al., 2007). Conversely, studies have also provided evidence
that disregards TLR signaling for initiating antibody responses
and supporting an instructive role for TLRs in augmenting
antibody isotypes (Gavin et al., 2006). Our results demon
strate a minor role for TLR3 signaling in optimal induction
of IgG2c by poly(I:C), supporting previous studies showing
that TLR signaling is largely unnecessary for efficient anti
body responses (Gavin et al., 2006). However, the ability of
Tlr3/ B cells to mount normal antibody responses in re
constituted hosts clearly negates a role for B cell–intrinsic
TLR3 signaling in IgG2c induction by poly(I:C). Discrepan
cies observed in the role of B cell–intrinsic TLR signaling
may be explained by a lack of direct conjugation of the TLR
agonist with antigen, whereby conjugation would allow for
the TLR agonist to be directed through BCR-mediated
internalization to responding B cells for concomitant TLR
signaling (Eckl-Dorna and Batista, 2009). Our data do not
exclude whether autonomous B cell expression of other
PRRs, such as MDA5, is required for the IgG2c TI-2 anti
body response. Whether B cell–intrinsic RIG-I–like helicase
signaling may affect antibody responses remains unclear but
would be interesting to address with a TLR3/ MDA5/
B cell chimeric model similar to that used here.
Our findings indicate that poly(I:C) is recognized pre
dominantly by TLR3 and MDA5 for subsequent indirect in
duction of the TI-2 IgG2c antibody response through type I
IFN. However, we note that in Tlr3/ Mda5/ double
knockout mice, poly(I:C) remains able to induce NP-specific
IgG2c but is 80% reduced compared with wild type
(Fig. 4 A), suggesting residual type I IFN induction. In ac
cordance with this, it has recently been reported that poly(I:C)
induction of CD4 T cell responses is incompletely abolished
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MATERIALS AND METHODS
Mice. C57BL/6 mice (The Jackson Laboratory) were used directly or bred
and maintained within the Biological Resource Center at National Jewish
Health (NJH; Denver, CO). C57BL/6-IghB1-8/B1-8;Igha mice (Sonoda et al.,
1997; gift from K. Rajewsky, Harvard University, Boston, MA) and B6.C20
mice (C57BL/6 mice congenic for Igha; gift from L. Herzenberg, Stanford
University, Palo Alto, CA) were both bred and maintained within the Bio
logical Resource Center at NJH. Ifnar1/ mice (Müller et al., 1994) on the
C57BL/6 genetic background were provided by P. Marrack (NJH, Denver,
CO). MDA5/ (Gitlin et al., 2006), Tlr3/, and Mda5/, Tlr3/ mice on
C57BL/6 genetic backgrounds were maintained at Washington University
(St. Louis, MO). Tlr3/ mice (Alexopoulou et al., 2001) on the C57BL/6
background were provided by R. Flavell (Yale University, New Haven,
CT) and also bred and housed within the NJH Biological Resource Center.
Animals were used between 8 and 12 wk of age, unless otherwise specified.
All experiments were performed in accordance with NJH and Washington
University Institutional Animal Care and Use Committees.
Flow cytometric analyses and antibodies. Spleen and lymph node cells
were harvested and stained according to standard protocols. Fluorescently
labeled mAbs against the following mouse surface antigens were used for
staining and either purchased or isolated and conjugated in our laboratory:
B220 (RA3-6B2; BD and eBioscience), IgM (R33-24.12; hybridoma),
IgMb (AF6-78; hybridoma), CD21 (7G6; hybridoma), CD19 (1D3; hybrid
oma and BD), CD1d (1B1; eBioscience), CD69 (H1.2F3; eBioscience),
CD86 (GL1; eBioscience), CD23 (B3B4; BD), TCR- (H57-597; BD),
IgHB1-8 (anti-idiotype; Ac146; hybridoma; Reth et al., 1979), IgMa (DS-1;
BD), Ig (JC5-1; SouthernBiotech), IgD (11-26c; BD), CD11a (2D7; BD),
IFNR1 (MAR1-5A3; BioLegend), and Mouse IgG1, isotype control
(MOPC-21; BD). For detection of NP-specific B cells by flow cytometry,
cells were stained with 4-Hydroxy-3-nitrophenylacetyl hapten conjugated
to Phycoerythrin (NP40–PE; Biosearch Technologies) after standard flow
cytometric staining protocol. The secondary detection reagent for detecting
biotin-conjugated antibodies by flow cytometry was streptavidin-PE (eBio
science). Flow cytometric analyses were performed by acquiring data on
either a FACSCalibur (BD) or a BD LSRII (BD) and with FlowJo v8.8.6
software (Tree Star, Inc.).
Immunizations. Mice were immunized i.p. with 5 µg NP (4-Hydroxy-3nitrophenylacetic) hapten conjugated to NP–Ficoll (Amino-Ethyl-CarboxyMethyl-FICOLL) at NP32–, NP41–, or NP50–Ficoll valencies (Biosearch
Technologies). Unless otherwise specified, the following doses of adjuvants
or cytokines were included with NP-Ficoll in immunizations as detailed:
100 µg poly(I:C) (polyinosine-polycytidylic acid; InvivoGen), 100 µg
Pam3CSK4 (N-Palmitoyl-S-[2,3-bis(palmitoyloxy)-(2, RS)-propyl]-[R]Cys-[S]-Ser-[S]-Lys4; InvivoGen), 100 µg 3M-012 (33080; TLR7 agonist;
3M Pharmaceuticals; gift from R. Kedl, NJH), or 8 × 105 U recombinant
mouse IFN-11 (Genbank accession no. AY225954; gift from R. Kedl,
NJH). Antigens, adjuvants, and cytokines were either purchased as endo
toxin free (≤0.125 EU/mg) or tested by an endpoint chromogenic Limulus
Amebocyte Lysate (LAL) assay (Cambrex) and found to be at levels ≤0.1 EU
per mouse for immunization.
NP-specific ELISAs. To measure NP-specific serum antibody responses,
96-well flat-bottom MaxiSorp MicroWell plates (Thermo Fisher Scientific)
were coated overnight with 2 µg/ml (4-Hydroxy-3-iodo-5-nitrophenylacetyl)
NIP15–BSA (Biosearch Technologies) diluted in PBS at 4°C. Plates were
washed once (PBS, 0.1% Tween 20; Thermo Fisher Scientific), blocked
(PBS, 1% BSA, and 0.05% NaN3) for a minimum of 2 h at 37°C, and washed
once again. For capture of antigen-specific antibodies, sera were initially di
luted 1:20 and subsequent threefold serial dilutions were made into blocking
buffer and incubated overnight at 4°C. Plates were washed three times be
fore incubation with an alkaline phosphatase (AP)–conjugated goat anti–
mouse isotype-specific detection antibody (SouthernBiotech) for 1 h at
37°C. After three washes, plates were developed by the addition of alkaline
1495
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loss of S1P1 responsiveness would also be expected to direct
TI-2 antigen-activated B cells to the T–B cell border where
associated TD antigens could be presented to antigen-specific
T cells.
Protective humoral immunity to pathogens is contributed
by distinct B cell subsets with unique activation requirements
and response patterns. Studies from dissected model patho
gens, such as S. pneumoniae and influenza, have taught us that
multifaceted protective humoral immune responses are com
prised by a collection of antibodies derived from distinct
B cell subsets (Baumgarth et al., 1999, 2008; Snapper, 2006).
Features that dictate which B cell subset responds have been
characterized, including the intrinsic responsiveness of each
B cell subset and the biochemical properties of the antigens.
Yet, it is still not understood how innate signals encountered
during these infections dictate which B cell subset participates
in each facet of the antibody response. The TI-2 response to
NP-Ficoll has been characterized by the domination of IgM
and IgG3 isotypes derived from MZ B cells (Otipoby et al.,
1996; Guinamard et al., 2000; Samardzic et al., 2002; Shih
et al., 2002). We demonstrate in this paper that in the pres
ence of type I IFN innate signals, FO B cells are rapidly pro
moted to participate in a switched TI-2 antibody response
through B cell–intrinsic IFN-/ signaling that leads to
antigen-specific IgG2c antibody production. Whether type I
IFN recruits additional FO B cells to respond to a TI-2 anti
gen or promotes enhanced clonal expansion of responding
antigen-specific FO B cells remains to be established.
Rapid low-affinity extrafollicular innate-like antibody
responses are crucial to providing early acquired immunity
against pathogens. This study provides the first direct evi
dence for an innate-like switched FO B cell antibody re
sponse to a TI-2 antigen. The participation by FO B cells to
this switched TI-2 response was unexpected given the longstanding model that FO B cells are a slower responding B cell
subset and predominately produce higher affinity postgerminal center antibodies during TD responses (Martin and
Kearney, 2002; McHeyzer-Williams, 2003). Economically,
one rationale behind the enhanced contribution of FO B
cells to providing the IFN-/–induced IgG2c response, as
opposed to the subset which produces the TI-2 IgM re
sponse, is that this division of labor allows for IgG2c induc
tion but not at the expense of the crucial initial IgM response.
Furthermore, this division of labor illustrates the importance
of both arms of the anti-pathogen humoral response: a rapid
IgM response to provide antibody capable of neutralizing and
controlling the infection and a robust and highly efficient
IgG2c response effective at specialized FcR-mediated clear
ance (Nimmerjahn and Ravetch, 2005, 2008). These findings
propose a novel role for FO B cells in responding to innate
signals in vivo to participate in innate-like antibody responses.
Future studies will be required to address whether a discreet
subset of innate FO B cells exist that solely have the capacity
to respond in this manner or whether this phenomenon is
a general characteristic of all FO B cells recruited in response
to particular innate signals.

NP-specific ELISPOTS. NP-specific ASCs were measured in 96-well
flat-bottom EIA/RIA high-binding plates (Costar; Corning) coated over
night at 4°C with 2 µg/ml NIP15-BSA diluted in 0.05 M K2HPO4, pH 8.0.
Plates were washed three times with PBS before blocking with warm PBS
and 1% gelatin (Sigma-Aldrich) at 37°C for a minimum of 1 h. Plates were
washed again three times with PBS before incubation with cells. Cells were
isolated from spleen, bone marrow, or lymph nodes at the times indicated
after immunization and seeded in duplicate at a starting density of 0.25–1 ×
107 total viable cells per 100 µl in the first well, and threefold serial dilutions
were performed down the plate. For those ELISPOTs performed on lymph
node cells, lymph nodes harvested from three mice within the same treat
ment group were pooled together to constitute a single sample. Cultured
cells were incubated at 37°C in 5% CO2 for 6 h in complete IMDM (Invit
rogen) supplemented with 10% heat-inactivated FBS (Biosource, Invitro
gen, or Gemini Bio-Products), 2 mM GlutaMAX-I (Invitrogen), 100 U/ml
Penicillin (Invitrogen), 100 µg/ml Streptomycin (Invitrogen), and 0.05 mM
2-mercaptoethanol (Sigma-Aldrich). Plates were then washed once with
H2O and 0.05% Tween 20 for 10 min at room temperature and subse
quently three times with PBS and 0.1% Tween 20. Secreted antibody was
detected by incubating plates with an isotype-specific AP-conjugated goat
anti–mouse Ig (SouthernBiotech) diluted in warm PBS, 1% gelatin, and
0.05% Tween 20 for 1 h at 37°C. After three washes (PBS, 0.1% Tween 20),
plates were developed overnight at 4°C with 1 mg/ml 5-Bromo-4chloro-3-indolyl phosphate p-toluidine (Sigma-Aldrich) salt substrate diluted
in an alkaline buffer composed of 0.1 M 2-amino-2-methyl-1-propanol,
0.01% NaN3, 0.5 mM MgCl2, and 0.007% Triton X-405, pH 10.25.
Plates were washed four times with deionized H2O, allowed to dry in the
dark at room temperature, and scanned (Perfection 2450 Photo Scanner;
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Epson). Developed spots were counted visually from the scanned images
and the frequency of NP-specific ASCs per total number of cells plated
was enumerated.
Splenectomy operations. For both vital splenectomy and sham opera
tions, 6-wk-old C57BL/6 mice were anesthetized by intraperitoneal injection
of 100 mg/kg ketamine and 10 mg/kg xylazine, followed by administration
of a subcutaneous injection of 0.5 mg/kg buprenorphine for pain. Once
sedated, a 1–1.5-cm incision was made on the upper left abdomen through
both the peritoneal wall and skin. For splenectomized animals, the spleen
was exteriorized and the splenic artery and efferent venule were each ligated.
For sham-operated mice, the spleen was gently replaced back into the abdo
men. For all animals, the abdominal wall was closed by placing one to two
sutures through the peritoneal membrane, and subsequently two wound
clips were placed to adjoin the exterior skin of the incision. Postoperative
care included administration of 1 ml of subcutaneous saline, rest near an in
direct heat source, and monitoring until full motility was regained. Pain
management was achieved by subcutaneous injections of 0.5 mg/kg bu
prenorphine every 12 h for 2–3 d after surgery. Mice were allowed to re
cover for 21–29 d after surgery, at which time the total serum IgM was
determined to be equivalent between the sham-operated and splenecto
mized groups. At 23–32 d after operation, mice were immunized and serum
NP-specific antibody responses measured by ELISA as described.
MZ B cell depletion. For selective MZ B cell depletion in vivo, a protocol
was used that was similar to a previously published protocol (Belperron et al.,
2005, 2007). In brief, C57BL/6 mice were injected i.p. with 100 µg each of
unconjugated purified rat IgG2a anti–mouse CD11a (Integrin L, LFA-1;
clone M17/4; hybridoma) and rat IgG2b anti–mouse CD49d (Integrin 4;
VLA-4; clone PS/2; hybridoma) mAbs diluted together in sterile PBS. Con
trol mice were injected with 100 µg each of functional grade purified rat
IgG2a (clone eBR2a; eBioscience) and rat IgG2b isotype control antibodies
(clone eB149/10H5; eBioscience) also diluted in PBS. 3 h after injection of
antibodies, mice were bled and PBLs stained for the mature B cell markers
CD21 and CD1d to verify MZ B cell release into blood. Greater than 80%
of MZ B cells are depleted entirely from the spleen up to 10 d after injection
of anti-integrin antibodies (Fig. S2 A), and by 14 d after treatment >60% of
normal frequencies of MZ B cells have returned to spleen (Fig. S2 A).
Approximately 10% of the anti-integrin antibodies injected remain within
circulation 4 d after injection and are essentially completely cleared by 7 d after
injection (Fig. S2 C). However, surface integrin expression is also downmodulated by the anti-4/L treatment on remaining T and B lymphocytes
up to 4 d after injection (Fig. S2D). Thus, for MZ B cell depletion experi
ments, mice were rested for 7 d after injection of anti-integrin antibodies and
before immunization (Fig. S2 E) to allow both for clearance of rat anti4/L antibodies (Fig. S2 C) and for remaining T and B lymphocytes to
regain wild-type levels of surface integrin expression (Fig. S2 D). 7 d after
injection of antibodies, mice were immunized with NP-Ficoll ± poly(I:C)
as described in Fig. S2 E. Sera were collected either the day before immuni
zation (preimmune) or at 4 and 7 d after immunization, and serum NPspecific antibody responses were measured as described. At 7 d after
immunization, splenocytes were harvested and the frequency of NP-specific
ASCs was evaluated by ELISPOT. Depleting anti-integrin antibodies were
tested by the LAL assay and found to be at levels ≤0.1 EU/ml.
To determine the clearance of serum rat IgG antibodies over time in
this model, serum was collected from mice injected with either rat IgG antiintegrin and isotype control antibodies and analyzed for the presence of rat
IgG by ELISA. In brief, plates were coated with 10 µg/ml of unlabeled goat
anti–rat IgM + IgG (H + L chain specific, absorbed against mouse Ig) anti
body in PBS overnight at 4°C. After washing (PBS and 0.1% Tween 20),
plates were blocked for 3 h at 37°C with preimmune C57BL/6 mouse serum
diluted 1:200 in PBS, 1% BSA, and 0.05% NaN3 and subsequently washed
twice. Sera and standards were diluted similarly as above and incubated over
night at 4°C. Plates were washed three times, and bound antibodies were
detected by incubation with AP-conjugated goat anti–rat IgG (H + L chain
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phosphatase substrate buffer consisting of 1 mg/ml 4-Nitrophenyl phosphate
disodium salt hexahydrate (Alkaline Phosphatase Substrate; Sigma-Aldrich)
diluted in 1 M diethanolamine, 8.4 mM MgCl2, and 0.02% NaN3, pH 9.8,
and absorbance values read at 405 nm (VersaMax ELISA reader; MDS
Analytical Technologies). The following NP-specific mouse mAbs were
used as standards to quantify the absolute concentration of NP-specific anti
body present in the sera of immunized mice: B1-8  (NP-specific IgM;
Reth et al., 1978), S24/63/63 (NP-specific IgG3; Baumhäckel et al., 1982),
N1G9 (NP-specific IgG1; Cumano and Rajewsky, 1985), S43-10 (NPspecific IgG2c; Reth et al., 1978), and D3-13F1 (NP-specific IgG2b; gift from
K. Rajewsky). In the cases where a standard was unavailable, the titer at an
OD50 was determined from the serial dilution curves for each sample.
For both adoptive transfer and mixed bone marrow chimera analyses,
detection of NP-specific IgG2a or IgG2c serum antibodies by ELISA
was accomplished with AP-conjugated AffiniPure goat anti–mouse IgG,
Fc Subclass 2a–specific (Jackson ImmunoResearch Laboratories), or APconjugated AffiniPure goat anti–mouse IgG, Fc Subclass 2c–specific (Jackson
ImmunoResearch) antibodies, respectively. The detection of NP-specific
IgMa or IgMb serum antibody responses was accomplished as previously
described (Rubtsov et al., 2005) with either biotin-conjugated mouse anti-IgMa
(DS-1; BD) or biotin-conjugated mouse anti-IgMb (AF6-78; BD) antibodies,
respectively. Plates were subsequently washed three times and bound antibody
revealed by incubation with AP-conjugated Streptavidin (Southern Biotech).
For affinity maturation measurements, ELISAs were performed as in the
previous paragraphs with the exception that plates were coated with either
NP (4-Hydroxy-3-nitrophenylacetyl)4–BSA or NP16–BSA capture antigens
(Biosearch Technologies) diluted at 2 µg/ml. The ratio of high-affinity anti
bodies bound to NP4–BSA relative to the total of both high- and lowaffinity antibodies bound to NP16–BSA was calculated as previously described
(Herzenberg et al., 1980; Cumano and Rajewsky, 1985). In brief, the rela
tive NP4/NP16 binding ratio for a given sample was calculated as the OD50
titer of serum antibodies bound to NP4–BSA divided by the OD50 titer of
antibodies bound to NP16–BSA. The NP-specific mAb S43-10 (Reth et al.,
1978) was used as a positive control for a high-affinity NP-specific IgG2c
antibody with an affinities of Kd = 2.4 × 108 M for NIP and Kd = 2.8 ×
107 M for NP (Cumano and Rajewsky, 1985).

Ar ticle

specific, absorbed against mouse Ig; SouthernBiotech) diluted in PBS, 1%
BSA, and 0.05% NaN3 buffer for 1 h at 37°C. After three washes, plates
were developed and absorbances read according to that described for the
NP-specific ELISA protocol. Purified unlabeled rat IgG antibody (Southern
Biotech) was used as a standard to quantify the concentration of total serum
rat IgG for these ELISAs.

Mixed bone marrow chimeras. Bone marrow cells were isolated from
5–7-wk-old C57BL/6 (Ighb), B6.C20 (Igha), Tlr3/ (Ighb), or Ifnar1/
(Ighb) donor mice in IMDM supplemented with 5% FBS under sterile con
ditions. Donor bone marrow cells were washed once with sterile PBS (Cell
gro; Mediatech, Inc.), resuspended at 1.33–2.67 × 107 cells/ml in PBS, and
mixed (Ighb + Igha) to yield a final concentration of 2 × 107 cells/ml for re
constitution. A total of 4 × 106 bone marrow cells were injected intrave
nously into each sex-matched lethally irradiated (1,000 rad) 6–8-wk-old
B6.C20 recipients. Recipient mice were maintained on Septra food for 7–8 wk
after reconstitution. At 8 wk after reconstitution, PBLs from chimeric mice
were analyzed by flow cytometric analysis to ensure no significant differ
ences were observed between the ratio of IgMb:IgMa B cell reconstitution
frequencies in the experimental chimeras as compared with the control chi
meras. Chimeric mice were immunized at 9 wk after reconstitution and
serum NP-specific antibody responses were measured by ELISA as described.
At 14 d after immunization, the ratio of IgMb:IgMa B cell reconstitution
frequencies was determined within the chimeric splenic mature B cell com
partments and found to be identical to those previously measured in the
circulating B cell population.
In vitro stimulation. B cells were negatively enriched from naive C57BL/6
mice by depletion of CD43+ cells with magnetic cell sorting on LS columns
(Miltenyi Biotec) with MACS buffer (PBS, 2 mM EDTA, and 0.5% BSA)
according to the manufacturer’s protocol. MZ (CD21high CD1dhigh) and FO
(CD21int CD1dint) B cells were subsequently sorted based on surface expres
sion of CD21 and CD1d to ≥94% purity using a MoFlo XDP Cell Sorter
(Beckman Coulter) with Summit Software version 5.1.3.6886. Sorted MZ
and FO B cells were cultured separately at 2.5–5 × 105 cells/ml in 1 ml of com
plete IMDM in 24-well flat bottom cell culture plates (CELLSTAR; Greiner
Bio-One) with the indicated stimuli at 37°C in 5% CO2. Stimuli and their
concentrations cultured with cells included the following: 1–100 U/ml re
combinant mouse IFN-11 (PBL InterferonSource), 1–10 µg/ml AffiniPure
F(ab)2 goat anti-mouse IgM,  chain specific (anti-IgM; Jackson Immuno
Research Laboratories), and 0.1–10 µg/ml LPS (Escherichia coli O26:B6;
Sigma-Aldrich). B cell activation was subsequently assessed as CD69 and
CD86 cell surface marker up-regulation measured by flow cytometry
after stimulation for 6 or 10 h, respectively. Endotoxin levels of stimuli
used for in vitro cultures were either measured by the LAL assay or purchased
as <1 EU/µg.
Immunofluorescence histology. Spleens were harvested from mice 7 d
after immunization and frozen in OCT compound (EM Sciences) at 80°C.
Tissues were cut into 5–7-µm sections and allowed to dry at room tempera
ture. Unfixed sections were rehydrated with PBS for 20 min and blocked
for 15–30 min with rat anti–mouse FcR blocking antibody (2.4G2) diluted
JEM VOL. 207, July 5, 2010

Statistical and data analyses. Data were graphed and analyzed using
Prism version 5.0a (GraphPad Software). Statistical significance was assessed
with a Student’s t test with unequal variance, and the appropriateness of onetailed or two-tailed significance was determined on an individual experiment
basis. P-values ≤0.05 were considered significant. Where appropriate, data
were expressed as the geometric mean ± SEM, unless otherwise stated.
Online supplemental material. Fig. S1 shows dose response of poly(I:C)
on the production of NP-specific IgG2c and lack of polyclonal IgG2c pro
duction. Data presented in Fig. S2 characterizes the kinetics of MZ B cell
depletion by anti-integrin treatment. Online supplemental material is avail
able at http://www.jem.org/cgi/content/full/jem.20092695/DC1.
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